Co-Investment Opportunity | Independent Sponsor Acquisition | Occupational Health & Safety

I'm an independent sponsor (trained physician and former VP, Goldman Sachs Healthcare IB) closing on a 30-year-old occupational health and safety platform based in Southeast U.S. Proprietarily sourced, QofE (Plante Moran) and insurance diligence complete, targeting a May/June close. Quick deal profile: • $12M revenue, $1.37M QofE-validated trough EBITDA • $8.0M enterprise value (5.8x trough EBITDA) • Effective entry on normalized EBITDA (~$2.4M): ~3.4x • Market comps for EHS/OHS at $2–5M EBITDA: 7.5–10.0x • Organic base case (assuming no entry leverage): 4.3x / 28% IRR at Year 5 • Downside (same-as-entry exit, no M&A, no entry leverage): 3.2x / 21% IRR • Management continuity. COO stepping into CEO seat Day-1. Other middle managers in place 70%+ of EBITDA comes from segments with toll-road economics — OSHA expert witness and safety audit, where client cost is immaterial relative to the litigation or regulatory exposure being mitigated. OSHA compliance is federally mandated and non-discretionary. The business was profitable through COVID. The revenue decline in 2025 is diagnosable: the company has never had a sales team (all revenue via word-of-mouth), and a key staffing client temporarily shuttered a facility. No outbound engine meant no replacement pipeline. We’re installing a Sales Lead on Day 1. This is a traditional PE-structured deal, not SBA — targeting all-equity entry with preferred equity terms for investors (8% PIK, 1.0x liq pref, 80% of common to investors, 20% promote behind pref). All-equity at entry buys us clean balance sheet for use of debt to drive the programmatic M&A strategy. I’ll be embedded full-time for the first 6–12 months alongside our operating partner. Looking for co-investors at $100K+ (individual) / $1M+ (institutional). Same terms for all investors. One-page teaser attached. CIM and financial model available under NDA. Feel free to DM or reach out at redacted